Vimarsana
Biggest News Aggregation in the World

Page 40 - Adverse Effects News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Adverse Effects. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Adverse Effects Today - Breaking & Trending Today

Not an oncologist? What you should still know about chemotherapy emergencies - Vimarsana News

Not an oncologist? What you should still know about chemotherapy emergencies

How to tackle chemotherapy adverse effects as a general practitioner or emergency veterinarian

Source: dvm360.com
EU Regulator to Discuss Anesthesia Risk for Weight-Loss Drugs - Vimarsana News

EU Regulator to Discuss Anesthesia Risk for Weight-Loss Drugs

The EMA will discuss the risk that patients on Wegovy, Ozempic, or similar drugs may suffer certain complications under anesthesia that can lead to pneumonia, according to an agenda posted on the regulator's website.

Clinical Overview: Lecanemab Use, Coverage for Alzheimer Disease - Vimarsana News

Clinical Overview: Lecanemab Use, Coverage for Alzheimer Disease

In clinical trials, lecanemab showed a reduction of amyloid beta plaque in patients with Alzheimer disease.

Adhering to Endocrine Therapy Is Hard. What Can Be Done? - Vimarsana News

Adhering to Endocrine Therapy Is Hard. What Can Be Done?

Poor adherence to adjuvant endocrine therapy remains an issue among patients with breast cancer. What can oncologists and patients do to improve long-term use?

Tirzepatide Tops Semaglutide for A1c Control, Weight Loss - Vimarsana News

Tirzepatide Tops Semaglutide for A1c Control, Weight Loss

A meta-analysis of studies on the two diabetes drugs shows stronger benefits with tirzepatide, with the caveat of some higher gastrointestinal effects with tirzepatide.